Byline: Madeleine Heffernan Oct 17, 2012 (The Age - ABIX via COMTEX) -- Chair John Shine on 17 October 2012 addressed the AGM of blood plasma products and vaccines manufacturer CSL. He announced a stock repurchasing scheme covering 4% of the issued scrip, worth $A900m. Shine was also joined by the ...
Read this article at Buyback, Profit Forecast Push CSL to Record High
Read this article at Buyback, Profit Forecast Push CSL to Record High